An Unusual Reaction to Etoposide

Abstract

Get full access to this article

View all access options for this article.

References

Rozencweig

Von Hoff

Henney

Muggia

. VM-26 and VP-16–213: a comparative analysis. Cancer 1977; 40: 334–42.

Dorr

Fritz

. Cancer chemotherapy handbook. New York: Elsevier, 1980: 420–1.

European Organization for Research on Treatment of Cancer. Epipodophyllotoxin VP-16-213 in treatment of acute leukemias, hematosarcomas and solid tumors. Br Med J 1973; 3: 199–202.

Jungi

Senn

. Clinical study of the new podophyllotoxin derivative, 4î-demethylepipodophyllotoxin 9-(4,6-O-ethylidene-β-D-glucopyranoside) VP-16-213 in solid tumors in man. Cancer Chemother Rep 1975; 59: 737–42.

McEvoy

GKED

. American Hospital Formulary Service drug information 88. Bethesda, MD: American Society of Hospital Pharmacists, 1988: 510–1.

Jacobs

King

Sealy

. Epipodophyllotoxin (VP-16-213) in the treatment of diffuse histiocytic lymphoma. S Afr Med J 1975; 49: 483–5.

Wolff

Fer

McKay

Hande

Hainsworth

Greco

. High-dose VP-16-213 and autologous bone marrow transplantation for refractory malignancies: a Phase I study. J Clin Oncol 1983; 1: 701–5.

Creaven

Newman

Selawry

. Phase I clinical trial of weekly administrations of 4îdemethylepiposophyllotoxin 9-(4,6-O ethylidene-β-D-glucopryanoside (VP-16-213). Cancer Chemother Rep 1974; 58: 901–7.

O'Dwer

Weiss

. Hypersensitivity reactions induced by etoposide. Cancer Treat Rep 1984; 68 (7–8): 859–61.